Fluidigm Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Hi, welcome to the Cantor Virtual Global Healthcare Conference. I'm Kyle Mikson. I cover life science tools and diagnostic stocks at Cantor and we're pleased to have Fluidigm here with us today.
Fluidigm creates, manufactures and markets technologies and tools for life sciences' research including prep and analytical instruments for mass cytometry, PCR, library prep, single-cell genomics and consumables. The company is playing a large role in COVID-19 testing effort which I'm sure we'd like to hear much more about in a few moments.
From Fluidigm, we have Chris Linthwaite, the company's President and CEO. If you have a question for Chris, please e-mail to me at [email protected] and I'll relay it to Chris at the end of this presentation. So, thanks for being here, Chris. I'll hand over the floor to you.
Thank you, Kyle, and I want to thank Cantor for the invitation to present at your Healthcare Conference.
So here we go, so the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |